—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Galenica Sante AG (GALE.SW) — the peer cohort

As of 2026-10-28 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

Galenica Sante AG ranks 9 of 9 in its cohort on the Closelooknet composite (46/100) — the cohort is led by BB Biotech AG at 74/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
GALE.SW Galenica Sante AG 46 53 31 61 info 13.4%
BION.SW BB Biotech AG 74 67 96 81 info 11.9%
YPSN.SW Ypsomed Holding AG 57 80 62 28 ok 6.1%
SOON.SW Sonova H Ag 56 94 73 49 watch 1.7%
BANB.SW Bachem Holding AG 51 83 42 34 ok 2.3%
HALO Halozyme Therapeutics Inc 73 98 94 38 ok 0.2%
DXCM DexCom Inc 65 77 80 38 bull 15.2%
UCB.BR UCB SA 65 66 70 53 info 6.1%
ANN.AU Ansell Ltd 64 96 47 56 ok 1.5%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-10-28

Quick answers

Who are Galenica Sante AG's peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: BB Biotech AG (BION.SW), Ypsomed Holding AG (YPSN.SW), Sonova H Ag (SOON.SW), Bachem Holding AG (BANB.SW), Halozyme Therapeutics Inc (HALO), DexCom Inc (DXCM), UCB SA (UCB.BR), Ansell Ltd (ANN.AU).

How does GALE.SW score against its peers?

Galenica Sante AG's composite reads 46/100, ranking 9 of 9 in its cohort as of 2026-10-28; the cohort's highest composite is BB Biotech AG at 74/100. Closelooknet scores are research diary readings, not ratings or advice.

Related in the Closelooknet universe

then Medical Distribution, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.